Prospects of Stem Cells for Retinal Diseases

Asia-Pacific Journal of Ophthalmology

Volumn 2, Issue 1, 2013, Pages 57-63

  Ng, Tsz Kin ^a   Lam, Dennis S C ^b   Cheung, Herman S ^a,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

^c University of Miami College of Engineering   (United States)

Author keywords

age related macular degeneration; diabetic retinopathy; glaucoma; retinitis pigmentosa; stem cell therapy

Indexed keywords

EID: 84946719750     PISSN: None     EISSN: 21620989     Source Type: Journal    
DOI: 10.1097/APO.0b013e31827e3e5d     Document Type: Article

References (68)

1. Glickstein, M, Organization of the visual pathways. Evidence is discussed concerning parallel pathways from the eye to the brain. Science 164 (1969), 917–926.
2. Quigley, HA, Number of people with glaucoma worldwide. Br J Ophthalmol 80 (1996), 389–393.
3. Weinreb, RN, Khaw, PT, Primary open-angle glaucoma. Lancet 363 (2004), 1711–1720.
4. Hartong, DT, Berson, E, Dryja, TP, Retinitis pigmentosa. Lancet 368 (2006), 1795–1809.
5. Gariano, RF, Gardner, TW, Retinal angiogenesis in development and disease. Nature 438 (2005), 960–966.
6. Pascolini, D, Mariotti, SP, Pokharel, GP, et al. 2002 global update of available data on visual impairment: a compilation of population-based prevalence studies. Ophthalmic Epidemiol 11 (2004), 67–115.
7. Bird, AC, Bressler, NM, Bressler, SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 39 (1995), 367–374.
8. Ng, TK, Liang, XY, Pang, CP, HTRA1 in age-related macular degeneration. Asia Pac J Ophthalmol 1 (2012), 51–63.
9. Ilic, D, Polak, JM, Stem cells in regenerative medicine: introduction. Br Med Bull 98 (2011), 117–126.
10. Wagers, AJ, Weissman, IL, Plasticity of adult stem cells. Cell 116 (2004), 639–648.
11. Conrad, S, Renninger, M, Hennenlotter, J, et al. Generation of pluripotent stem cells from adult human testis. Nature 456 (2008), 344–349.
12. Jiang, Y, Jahagirdar, BN, Reinhardt, RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418 (2002), 41–49.
13. Notta, F, Doulatov, S, Laurenti, E, et al. Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. Science 333 (2011), 218–221.
14. Huang, CY, Pelaez, D, Dominguez-Bendala, J, et al. Plasticity of stem cells derived from adult periodontal ligament. Regen Med 4 (2009), 809–821.
15. Takahashi, K, Tanabe, K, Ohnuki, M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131 (2007), 861–872.
16. Yu, J, Vodyanik, MA, Smuga-Otto, K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318 (2007), 1917–1920.
17. Zhao, X, Liu, J, Ahmad, I, Differentiation of embryonic stem cells into retinal neurons. Biochem Biophys Res Commun 297 (2002), 177–184.
18. Ikeda, H, Osakada, F, Watanabe, K, et al. Generation of RxPax6 neural retinal precursors from embryonic stem cells. Proc Natl Acad Sci U S A 102 (2005), 11331–11336.
19. Lamba, DA, Karl, MO, Ware, CB, et al. Efficient generation of retinal progenitor cells from human embryonic stem cells. Proc Natl Acad Sci U S A 103 (2006), 12769–12774.
20. Osakada, F, Ikeda, H, Mandai, M, et al. Toward the generation of rod and cone photoreceptors from mouse, monkey and human embryonic stem cells. Nat Biotechnol 26 (2008), 215–224.
21. Hirami, Y, Osakada, F, Takahashi, K, et al. Generation of retinal cells from mouse and human induced pluripotent stem cells. Neurosci Lett 458 (2009), 126–131.
22. Hambright, D, Park, KY, Brooks, M, et al. Long-term survival and differentiation of retinal neurons derived from human embryonic stem cell lines in un-immunosuppressed mouse retina. Mol Vis 18 (2012), 920–936.
23. Lamba, DA, Gust, J, Reh, TA, Transplantation of human embryonic stem cell-derived photoreceptors restores some visual function in Crx-deficient mice. Cell Stem Cell 4 (2009), 73–79.
24. Amirpour, N, Karamali, F, Rabiee, F, et al. Differentiation of human embryonic stem cell-derived retinal progenitors into retinal cells by Sonic hedgehog andor retinal pigmented epithelium and transplantation into the subretinal space of sodium iodate-injected rabbits. Stem Cells Dev 21 (2012), 42–53.
25. Lu, B, Malcuit, C, Wang, S, et al. Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration. Stem Cells 27 (2009), 2126–2135.
26. Tucker, BA, Park, IH, Qi, SD, et al. Transplantation of adult mouse iPS cell-derived photoreceptor precursors restores retinal structure and function in degenerative mice. PLoS One, 6, 2011, e18992.
27. Stitt, AW, ONeill, CL, ODoherty, MT, et al. Vascular stem cells and ischaemic retinopathies. Prog Retin Eye Res 30 (2011), 149–166.
28. Caballero, S, Sengupta, N, Afzal, A, et al. Ischemic vascular damage can be repaired by healthy, but not diabetic, endothelial progenitor cells. Diabetes 56 (2007), 960–967.
29. Park, SS, Caballero, S, Bauer, G, et al. Long-term effects of intravitreal injection of GMP-grade bone-marrow-derived CD34 cells in NOD-SCID mice with acute ischemia-reperfusion injury. Invest Ophthalmol Vis Sci 53 (2012), 986–994.
30. Sun, X, Jiang, H, Yang, H, In vitro culture of bone marrow mesenchymal stem cells in rats and differentiation into retinal neural-like cells. J Huazhong Univ Sci Technolog Med Sci 27 (2007), 598–600.
31. Vossmerbaeumer, U, Ohnesorge, S, Kuehl, S, et al. Retinal pigment epithelial phenotype induced in human adipose tissue-derived mesenchymal stromal cells. Cytotherapy 11 (2009), 177–188.
32. Hill, AJ, Zwart, I, Tam, HH, et al. Human umbilical cord blood-derived mesenchymal stem cells do not differentiate into neural cell types or integrate into the retina after intravitreal grafting in neonatal rats. Stem Cells Dev 18 (2009), 399–409.
33. Lund, RD, Wang, S, Lu, B, et al. Cells isolated from umbilical cord tissue rescue photoreceptors and visual functions in a rodent model of retinal disease. Stem Cells 25 (2007), 602–611.
34. Inoue, Y, Iriyama, A, Ueno, S, et al. Subretinal transplantation of bone marrow mesenchymal stem cells delays retinal degeneration in the RCS rat model of retinal degeneration. Exp Eye Res 85 (2007), 234–241.
35. Johnson, TV, Bull, ND, Hunt, DP, et al. Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma. Invest Ophthalmol Vis Sci 51 (2010), 2051–2059.
36. Li, N, Li, XR, Yuan, JQ, Effects of bone-marrow mesenchymal stem cells transplanted into vitreous cavity of rat injured by ischemiareperfusion. Graefes Arch Clin Exp Ophthalmol 247 (2009), 503–514.
37. Yang, Z, Li, K, Yan, X, et al. Amelioration of diabetic retinopathy by engrafted human adipose-derived mesenchymal stem cells in streptozotocin diabetic rats. Graefes Arch Clin Exp Ophthalmol 248 (2010), 1415–1422.
38. Bull, ND, Martin, KR, Using stem cells to mend the retina in ocular disease. Regen Med 4 (2009), 855–864.
39. Siqueira, RC, Voltarelli, JC, Messias, AM, et al. Possible mechanisms of retinal function recovery with the use of cell therapy with bone marrow-derived stem cells. Arq Bras Oftalmol 73 (2010), 474–479.
40. Nauta, AJ, Fibbe, WE, Immunomodulatory properties of mesenchymal stromal cells. Blood 110 (2007), 3499–3506.
41. West, EL, Pearson, RA, MacLaren, RE, et al. Cell transplantation strategies for retinal repair. Prog Brain Res 175 (2009), 3–21.
42. Niederkorn, JY, Immune privilege and immune regulation in the eye. Adv Immunol 48 (1990), 191–226.
43. Cheung, CY, Leung, CK, Lin, D, et al. Relationship between retinal nerve fiber layer measurement and signal strength in optical coherence tomography. Ophthalmology 115 (2008), 1347–1351.
44. Lai, TY, Chan, WM, Lai, RY, et al. The clinical applications of multifocal electroretinography: a systematic review. Surv Ophthalmol 52 (2007), 61–96.
45. Schwartz, SD, Hubschman, JP, Heilwell, G, et al. Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 379 (2012), 713–720.
46. Jonas, JB, Witzens-Harig, M, Arseniev, L, et al. Intravitreal autologous bone marrow-derived mononuclear cell transplantation: a feasibility report. Acta Ophthalmol 86 (2008), 225–226.
47. Siqueira, RC, Messias, A, Voltarelli, JC, et al. Intravitreal injection of autologous bone marrow-derived mononuclear cells for hereditary retinal dystrophy: a phase I trial. Retina 31 (2011), 1207–1214.
48. Charron, D, Suberbielle-Boissel, C, Al-Daccak, R, Immunogenicity and allogenicity: a challenge of stem cell therapy. J Cardiovasc Transl Res 2 (2009), 130–138.
49. Chen, PM, Yen, ML, Liu, KJ, et al. Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells. J Biomed Sci, 18, 2011, 49.
50. Wada, N, Menicanin, D, Shi, S, et al. Immunomodulatory properties of human periodontal ligament stem cells. J Cell Physiol 219 (2009), 667–676.
51. Zarzeczny, A, Caulfield, T, Emerging ethical, legal and social issues associated with stem cell research and the current role of the moral status of the embryo. Stem Cell Rev 5 (2009), 96–101.
52. Hayden, EC, Stem cells: the growing pains of pluripotency. Nature 473 (2011), 272–274.
53. Kim, D, Kim, CH, Moon, JI, et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4 (2009), 472–476.
54. Shi, Y, Desponts, C, Do, JT, et al. Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 3 (2008), 568–574.
55. Gore, A, Li, Z, Fung, HL, et al. Somatic coding mutations in human induced pluripotent stem cells. Nature 471 (2011), 63–67.
56. Hussein, SM, Batada, NN, Vuoristo, S, et al. Copy number variation and selection during reprogramming to pluripotency. Nature 471 (2011), 58–62.
57. Mayshar, Y, Ben-David, U, Lavon, N, et al. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 7 (2010), 521–531.
58. Lister, R, Pelizzola, M, Kida, YS, et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 471 (2011), 68–73.
59. Kuroda, Y, Kitada, M, Wakao, S, et al. Unique multipotent cells in adult human mesenchymal cell populations. Proc Natl Acad Sci U S A 107 (2010), 8639–8643.
60. Kawanabe, N, Murata, S, Murakami, K, et al. Isolation of multipotent stem cells in human periodontal ligament using stage-specific embryonic antigen-4. Differentiation 79 (2010), 74–83.
61. Tang, C, Lee, AS, Volkmer, JP, et al. An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells. Nat Biotechnol 29 (2011), 829–834.
62. Lysaght, T, Campbell, AV, Regulating autologous adult stem cells: the FDA steps up. Cell Stem Cell 9 (2011), 393–396.
63. Ong, JM, da Cruz, L, A review and update on the current status of stem cell therapy and the retina. Br Med Bull 102 (2012), 133–146.
64. Quevedo, HC, Hatzistergos, KE, Oskouei, BN, et al. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci U S A 106 (2009), 14022–14027.
65. Streilein, JW, Ma, N, Wenkel, H, et al. Immunobiology and privilege of neuronal retina and pigment epithelium transplants. Vision Res 42 (2002), 487–495.
66. Ballios, BG, Cooke, MJ, van der Kooy, D, et al. A hydrogel-based stem cell delivery system to treat retinal degenerative diseases. Biomaterials 31 (2010), 2555–2564.
67. Thomson, HA, Treharne, AJ, Walker, P, et al. Optimisation of polymer scaffolds for retinal pigment epithelium (RPE) cell transplantation. Br J Ophthalmol 95 (2011), 563–568.
68. Trounson, A, Thakar, RG, Lomax, G, et al. Clinical trials for stem cell therapies. BMC Med, 9, 2011, 52.